Eli Lilly stock: LLY ends higher after $3.5 billion Pennsylvania plant plan as earnings near
Eli Lilly shares closed Friday up 1.3% at $1,037.15 after announcing a $3.5 billion injectable weight-loss drug plant in Pennsylvania. The facility, set for Fogelsville, will create 850 permanent jobs and is expected to open in 2031. Pennsylvania will contribute $100 million. Investors await Lilly’s Feb. 4 earnings release.